A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.
Epistemonikos ID: 684fe05eb02430ccb71682da685cf24a57fe02a1
First added on: Aug 12, 2026